je.st
news
Dolomite's Microfluidics Technology Helping to Advance Antibody Therapeutics
2015-01-16 11:30:53| Industrial Newsroom - All News for Today
Dolomite's droplet generation system is helping AbVitro to identify potential therapeutic targets using its AbPair technology. Dr Adrian Briggs, Director of Molecular Biology RD at AbVitro, commented: "Our aim is to develop new potential targets and therapies for a wide range of diseases, taking advantage of the...
Tags: technology
advance
helping
antibody
Category:Industrial Goods and Services
Latest from this category |
All news |
||||||||||||||||||||
|
|